Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review
Open Access
- 1 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Oxford Open Immunology
- Vol. 2 (1) , iqab001
Abstract
The role of obesity in the pathophysiology of respiratory virus infections has become particularly apparent during the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, where obese patients are twice as likely to suffer from severe coronavirus disease 2019 (COVID-19) than healthy weight individuals. Obesity results in disruption of systemic lipid metabolism promoting a state of chronic low-grade inflammation. However, it remains unclear how these underlying metabolic and cellular processes promote severe SARS-CoV-2 infection. Emerging data in SARS-CoV-2 and Influenza A virus (IAV) infections show that viruses can further subvert the host’s altered lipid metabolism and exploit obesity-induced alterations in immune cell metabolism and function to promote chronic inflammation and viral propagation. In this review, we outline the systemic metabolic and immune alterations underlying obesity and discuss how these baseline alterations impact the immune response and disease pathophysiology. A better understanding of the immunometabolic landscape of obese patients may aid better therapies and future vaccine design.Keywords
This publication has 106 references indexed in Scilit:
- Proteomic analysis of protein palmitoylation in adipocytesAdipocyte, 2013
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory DevelopmentImmunity, 2012
- B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodiesNature Medicine, 2011
- Lipid accumulation and dendritic cell dysfunction in cancerNature Medicine, 2010
- Palmitoylation of the Influenza A Virus M2 Protein Is Not Required for Virus Replication In Vitro but Contributes to Virus VirulenceJournal of Virology, 2009
- Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parametersNature Medicine, 2009
- Enhancing CD8 T-cell memory by modulating fatty acid metabolismNature, 2009
- Omental Milky Spots Develop in the Absence of Lymphoid Tissue-Inducer Cells and Support B and T Cell Responses to Peritoneal AntigensImmunity, 2009
- ACE2 is expressed in mouse adipocytes and regulated by a high-fat dietAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetesNature Reviews Molecular Cell Biology, 2008